GlassScriptPhysician profile
Guillermo E Patino
NPI 1356469761
$14,729.34
in general payments reported to CMS, 2019-2025
50 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,704 · 2020: $1,159 · 2021: $3,979 · 2022: $1,600 · 2023: $1,205 · 2024: $2,335 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,428 · Travel and Lodging: $682 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,428.34 |
| Travel and Lodging | $681.82 |
| Education | $176.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,013.09 | 2021-2022 | |
| Neotract INC. | $2,415.00 | 2019-2020 | |
| Medtronic, INC. | $1,486.75 | 2021-2025 | Interstim |
| Coloplast Corp | $1,433.00 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $1,017.84 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $833.70 | 2019-2025 | Myrbetriq, Veozah, Padcev |
| Medtronic USA, INC. | $515.90 | 2019-2020 | |
| Janssen Biotech, INC. | $434.98 | 2024-2025 | Erleada |
| Teleflex LLC | $414.17 | 2020-2024 | |
| Telix Pharmaceuticals | $262.23 | 2023-2025 | Illuccix |
| Endo Pharmaceuticals INC. | $253.66 | 2019-2023 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $250.55 | 2019-2024 | Provenge |
| Boston Scientific Corporation | $237.01 | 2019-2025 | Rezum Generator, Lithovue, General - Erectile Dysfunction |
| Myovant Sciences INC. | $208.48 | 2021-2022 | |
| Pfizer INC. | $162.43 | 2022-2025 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guillermo Patino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.